Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
95 Results Found
340B Advocacy Alliance Bulletin: Digital Ad Campaign Urges Policymakers To Protect 340B, Cautions Of Threats Posed By Drug Companies
The AHA, along with other national hospital groups, is running a new digital ad campaign promoting to policymakers and influencers the benefits of the 340B program to patients and communities.
340B Advocacy Alliance Bulletin: AHA Urges HHS to Ensure Hospitals Quickly Receive Withheld 340B Funds
AHA last week asked the Department of Health and Human Services to ensure hospitals quickly receive the funding to which they are entitled under the June 15 Supreme Court decision in American Hospital Association v. Becerra, without penalizing the rest of the hospital field.
340B Advocacy Alliance Bulletin: Supreme Court Rules Unanimously in Favor of AHA, Others in 340B Case
The Supreme Court of the United States today ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program, and thereby threatening access to care for patients.
340B Advocacy Alliance Bulletin May 12, 2022
The Health Resources and Services Administration late last week told Merck that it must immediately begin offering its covered outpatient drugs at the 340B ceiling price to covered entities through their contract pharmacy arrangements, regardless of whether they purchase through an in-house pharmacy.
340B Advocacy Alliance Bulletin - April 20, 2022
Reminder: Deadline is April 29 to Submit Information to AHA.
340B Advocacy Alliance Bulletin: Updates on 340B Legislation, Representatives Letter to HHS
Updates on 340B Legislation, Representatives Letter to HHS
340B Advocacy Alliance: Key Takeaways and Insights from Today’s Supreme Court Oral Arguments in AHA’s 340B Case
The Supreme Court of the United States today heard oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program, threatening access to care for patients.
AHA 340B Advocacy Alliance Bulletin: Get Live Analysis of Today's Supreme Court’s Oral Arguments in AHA’s 340B Case
The Supreme Court of the United States today, Nov. 30 will hear oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program, threatening access care for patients.
340B Advocacy Alliance Bulletin - AHA Files Reply Brief in 340B Case Before the U.S. Supreme Court
The AHA last Friday called the government’s defense of the decision by the Department of Health and Human Services to cut reimbursement to certain hospitals participating in the 340B program by nearly 30% “meritless” as it again urged the U.S. Supreme Court to overturn a lower court decision upholding the agency’s authority to make the cut.